{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:40:13Z","timestamp":1762864813993},"reference-count":55,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.peptides.2004.05.027","type":"journal-article","created":{"date-parts":[[2004,9,18]],"date-time":"2004-09-18T15:07:10Z","timestamp":1095520030000},"page":"1789-1794","source":"Crossref","is-referenced-by-count":27,"title":["Urotensin II and cardiovascular diseases"],"prefix":"10.1016","volume":"25","author":[{"given":"George","family":"Thanassoulis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thao","family":"Huyhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adel","family":"Giaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2004.05.027_bib1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/45809","article-title":"Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14","volume":"401","author":"Ames","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2004.05.027_bib2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/sj.bjp.0705254","article-title":"Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice","volume":"139","author":"Behm","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2004.05.027_bib3","first-page":"533","article-title":"Neurohormones from fish tails: the caudal neurosecretory system I","volume":"41","author":"Bern","year":"1985","journal-title":"Rec Prog Horm Res"},{"key":"10.1016\/j.peptides.2004.05.027_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/sj.bjp.0704448","article-title":"Urotensin II evokes potent vasoconstriction in humans in vivo","volume":"135","author":"Bohm","year":"2002","journal-title":"Br J Pharamacol"},{"key":"10.1016\/j.peptides.2004.05.027_bib5","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/sj.bjp.0703513","article-title":"Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries","volume":"130","author":"Bottrill","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2004.05.027_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00210-001-0503-0","article-title":"Effects of human urotensin-II in isolated vessels of various species; comparison with other vasoactive agents","volume":"36","author":"Camarda","year":"2002","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.peptides.2004.05.027_bib7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/(SICI)1097-010X(19960601\/15)275:2\/3<226::AID-JEZ14>3.0.CO;2-H","article-title":"Distribution and molecular forms of urotensin-II and its role in cardiovascular regulation in vertebrates","volume":"275","author":"Conlon","year":"1996","journal-title":"J Exp Zool"},{"key":"10.1016\/j.peptides.2004.05.027_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0167-0115(97)02135-6","article-title":"Somatostatin- and urotensin-II related peptides: molecular diversity and evolutionary perspectives","volume":"69","author":"Conlon","year":"1997","journal-title":"Regul Pep"},{"key":"10.1016\/j.peptides.2004.05.027_bib9","doi-asserted-by":"crossref","first-page":"15803","DOI":"10.1073\/pnas.95.26.15803","article-title":"Cloning of the cDNA encoding urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord","volume":"95","author":"Coulouarn","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.peptides.2004.05.027_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0014-5793(99)01003-0","article-title":"Lihrmann I. Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin-II precursors","volume":"457","author":"Coulouarn","year":"1999","journal-title":"FEBS Lett"},{"issue":"Suppl. 1","key":"10.1016\/j.peptides.2004.05.027_bib11","first-page":"2993","article-title":"Characterization of human urotensin-II as the most potent vasoconstrictor identified","volume":"100","author":"Douglas","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2004.05.027_bib12","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/sj.bjp.0703690","article-title":"Differential vasoconstrictor activity of the human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey","volume":"131","author":"Douglas","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2004.05.027_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1471-4892(03)00012-2","article-title":"Human urotensin-II as a novel cardiovascular target: \u2018heart\u2019 of the matter or simply a fishy \u2018tail\u2019?","volume":"3","author":"Douglas","year":"2003","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.peptides.2004.05.027_bib14","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/S0140-6736(02)08831-1","article-title":"Congestive heart failure and expression of myocardial urotensin II","volume":"359","author":"Douglas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2004.05.027_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0167-0115(02)00158-1","article-title":"Plasma levels and cardiovascular expression of urotensin-II in human heart failure","volume":"110","author":"Dschietzig","year":"2002","journal-title":"Regul Pep"},{"key":"10.1016\/j.peptides.2004.05.027_bib16","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/sj.bjp.0704051","article-title":"Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats","volume":"132","author":"Gardiner","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2004.05.027_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1476-5381.1987.tb09000.x","article-title":"Complex effects of Gillich-thys urotensin-II on rat aortic strips","volume":"91","author":"Gibson","year":"1987","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2004.05.027_bib18","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.2042-7158.1988.tb06298.x","article-title":"The influence of urotensin-II on calcium flux in rat aorta","volume":"40","author":"Gibson","year":"1998","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.peptides.2004.05.027_bib19","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.2042-7158.1988.tb06298.x","article-title":"The influence of urotensin-II on calcium influx in rat aorta","volume":"40","author":"Gibson","year":"1998","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.peptides.2004.05.027_bib20","first-page":"357","article-title":"Vasodepressor effects of urotensin II in rats","volume":"14","author":"Hasegawa","year":"1992","journal-title":"Neuroendocrinol Lett"},{"key":"10.1016\/j.peptides.2004.05.027_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1139\/y03-004","article-title":"Effect of human urotensin-II infusion on hemodynamics and cardiac function","volume":"81","author":"Hassan","year":"2003","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.peptides.2004.05.027_bib22","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0168-8278(02)00295-7","article-title":"Increase urotensin-II plasma levels in patients with cirrhosis and portal hypertension","volume":"37","author":"Heller","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.peptides.2004.05.027_bib23","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1161\/01.CIR.103.10.1378","article-title":"Effects of urotensin-II in human arteries and veins of varying caliber","volume":"103","author":"Hillier","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2004.05.027_bib24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1476-5381.1991.tb12516.x","article-title":"Contraction of rat thoracic aorta strips by endothelin-1 in the absence of extracellular Ca 2+","volume":"104","author":"Itoh","year":"1991","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2004.05.027_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0014-2999(88)90042-8","article-title":"Functional receptors for fish neuropeptide urotensin-II in majot rat arteries","volume":"149","author":"Itoh","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2004.05.027_bib26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/gcen.1998.7166","article-title":"Native urotensins influence cortisol secretion and plasma cortisol concentrations in the euryhaline flounder, Platichthys flesus","volume":"112","author":"Kelsall","year":"1998","journal-title":"Gen Comp Endocrinol"},{"issue":"Suppl.","key":"10.1016\/j.peptides.2004.05.027_bib27","first-page":"542","article-title":"Human urotensin-II causes vasoconstriction in the human skin microcirculation","volume":"102","author":"Leslie","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2004.05.027_bib28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.bjp.0703601","article-title":"Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1","volume":"131","author":"Maguire","year":"2000","journal-title":"Br J Phramacol"},{"key":"10.1016\/j.peptides.2004.05.027_bib29","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1097\/00004872-200112000-00011","article-title":"Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues","volume":"19","author":"Matsushita","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.peptides.2004.05.027_bib30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/geno.1995.9996","article-title":"Cloning and chromosomal mapping of three novel genes, GPR9 GPR10 and GPR 14 encoding receptors related to interleukin-8, neuropeptide Y and somatostatin receptors","volume":"29","author":"Marchese","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.peptides.2004.05.027_bib31","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1161\/01.CIR.0000044388.19119.02","article-title":"Plasma urotensin in human systolic heart failure","volume":"106","author":"Ng","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2004.05.027_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/14081","article-title":"Identification of the natural ligand of an orphan G-protein coupled receptor involved in the regulation of vasoconstriction","volume":"1","author":"Nothacker","year":"1999","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.peptides.2004.05.027_bib33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1472-8206.2001.00032.x","article-title":"Comparison of the contractile responses of human coronary bypass grafts and monkey arteries to human urotensin-II","volume":"15","author":"Paysant","year":"2001","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.peptides.2004.05.027_bib34","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1073\/pnas.77.8.5021","article-title":"Urotensin II: somatostatin like peptide in the caudal neurosecretory system of fishes","volume":"77","author":"Pearson","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.peptides.2004.05.027_bib35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(02)09709-X","article-title":"Plasma urotensin II in heart failure","volume":"360","author":"Richards","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2004.05.027_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0016-6480(86)90162-0","article-title":"In vitro effects of somatostatin and urotensin II on prolactin and growth hormone secretion in tilapia Oreochromis mossambicus","volume":"63","author":"Rivas","year":"1986","journal-title":"Gen Comp Endocrinol"},{"key":"10.1016\/j.peptides.2004.05.027_bib37","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1152\/ajpheart.00217.2003","article-title":"Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure","volume":"285","author":"Russell","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.peptides.2004.05.027_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0014-2999(02)01341-9","article-title":"Human urotensin-II induced aorta ring contractions are mediated by protein kinase C, tyrosine kinase and Rho-kinase: inhibition by somatostatin receptor antagonists","volume":"438","author":"Rossowski","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2004.05.027_bib39","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/hh1101.092034","article-title":"Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase","volume":"88","author":"Sauzeau","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.peptides.2004.05.027_bib40","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/002215540205000702","article-title":"Localization of urotensin-II immunoreactivity in normal human kidneys and renal carcinoma","volume":"50","author":"Shenouda","year":"2002","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.peptides.2004.05.027_bib41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0167-0115(86)90175-8","article-title":"Both somatostatin and the caudal neuropeptide, urotensin II, stimulate lipid mobilization from coho salmon liver incubated in vitro","volume":"14","author":"Sheridan","year":"1986","journal-title":"Regul Pep"},{"key":"10.1016\/j.peptides.2004.05.027_bib42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-2001-15414","article-title":"Inhibition of insulin release by urotensin II \u2013 a study on the perfused rat pancreas","volume":"33","author":"Silvestre","year":"2001","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.peptides.2004.05.027_bib43","first-page":"H925","article-title":"Potent vasodilator responses to human urotensin-II in human pulmonary resistance arteries: comparison with adrenomedullin and other vasodilators in pulmonary arteries","volume":"280","author":"Stirrat","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1016\/j.peptides.2004.05.027_bib44","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0196-9781(01)00441-7","article-title":"Expression of urotensin II and urotensin II receptor mRNAs in various human tumor cell lines and secretion of urotensin II-like immunoreactivity by SW-13 adrenocortical carcinoma cells","volume":"22","author":"Takahashi","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2004.05.027_bib45","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1006\/bbrc.1995.1563","article-title":"A novel putative neuropeptide receptor expressed in neural tissue, including sensory epithelia","volume":"209","author":"Tal","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.peptides.2004.05.027_bib46","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0024-3205(02)02346-9","article-title":"Urotensin-II-induced activation of extracellular signal-regulated kinase in cultured vascular smooth muscle cells: involvement of cell adhesion-mediated integrin signaling","volume":"72","author":"Tamura","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2004.05.027_bib47","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(01)06002-0","article-title":"Role of urotensin-II in patients on dialysis","volume":"358","author":"Totsune","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2004.05.027_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20020271","article-title":"Increased plasma urotensin II levels in patients with diabetes mellitus","volume":"104","author":"Totsune","year":"2003","journal-title":"Clin Sci"},{"key":"10.1016\/j.peptides.2004.05.027_bib49","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.RES.0000084382.64418.BC","article-title":"Direct actions of urotensin-II on the heart Implications for cardiac fibrosis and hypertrophy","volume":"93","author":"Tzanidis","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.peptides.2004.05.027_bib50","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/hc2601.092848","article-title":"Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells","volume":"104","author":"Watanabe","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2004.05.027_bib51","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/01.HYP.0000084633.85427.E6","article-title":"Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions","volume":"42","author":"Watson","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2004.05.027_bib52","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s00125-003-1145-1","article-title":"Role of urotensin II in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects","volume":"46","author":"Wenyi","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2004.05.027_bib53","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0008-6363(01)00485-0","article-title":"High plasma concentrations of human urotensin-II do not alter local or systemic hemodynamics in man","volume":"53","author":"Wilkinson","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.peptides.2004.05.027_bib54","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1081\/RRS-120014593","article-title":"Urotensin II mediates ERK1\/2 phosphorylation and proliferation in GPR14-transfected cell lines","volume":"22","author":"Ziltener","year":"2002","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1016\/j.peptides.2004.05.027_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-5793(01)03015-0","article-title":"Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats","volume":"508","author":"Zou","year":"2001","journal-title":"FEBS Lett"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019697810400333X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019697810400333X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T20:50:43Z","timestamp":1549227043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019697810400333X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S019697810400333X"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2004.05.027","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}